Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Dec;151(6):1517–1522.

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

C Parravinci 1, M Corbellino 1, M Paulli 1, U Magrini 1, M Lazzarino 1, P S Moore 1, Y Chang 1
PMCID: PMC1858372  PMID: 9403701

Abstract

Castleman's disease is a rare B cell lymphoproliferative disorder related to excess interleukin-6 (IL-6)-like activity. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8), which encodes a functional cytokine (vIL-6), has been found in some patients with Castleman's disease. Lymph nodes from 14 HIV-seronegative Castleman's disease patients were compared to hyperplastic lymph nodes from 25 HIV-seronegative patients as well as Kaposi's sarcoma lesions from 48 patients for KSHV infection and vIL-6, human IL-6, and Epstein-Barr virus EBER expression. While all Kaposi's sarcoma tissues examined were polymerase chain reaction-positive and all control lymph nodes were polymerase chain reaction-negative for KSHV, none had detectable vIL-6 expression. Six of 14 (43%) Castleman's tissues were positive for KSHV by polymerase chain reaction and all 6 had evidence of vIL-6 expression by immunohistochemistry. vIL-6-positive Castleman's disease patients generally had the multicentric plasma cell variant form of the disease and had a rapidly fatal clinical course frequently associated with autoimmune hemolytic anemia and gammopathy. In contrast, 7 (88%) of the 8 vIL-6-negative Castleman's disease patients had localized disease and have remained disease-free after therapy. KSHV vIL-6 expression appears to be limited to hematopoietic cells and is not present in Kaposi's sarcoma spindle cells. These data suggest that Castleman's disease is a syndrome of multiple etiologies involving aberrant IL-6 activity from either endogenous or viral sources.

Full text

PDF
1517

Images in this article

1519Figure 1. A
on p.1519
1520Figure 2. A
on p.1520

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck J. T., Hsu S. M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994 Mar 3;330(9):602–605. doi: 10.1056/NEJM199403033300904. [DOI] [PubMed] [Google Scholar]
  2. Bigoni B., Dolcetti R., de Lellis L., Carbone A., Boiocchi M., Cassai E., Di Luca D. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis. 1996 Mar;173(3):542–549. doi: 10.1093/infdis/173.3.542. [DOI] [PubMed] [Google Scholar]
  3. Brandt S. J., Bodine D. M., Dunbar C. E., Nienhuis A. W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990 Aug;86(2):592–599. doi: 10.1172/JCI114749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brandt S. J., Bodine D. M., Dunbar C. E., Nienhuis A. W. Retroviral-mediated transfer of interleukin-6 into hematopoietic cells of mice results in a syndrome resembling Castleman's disease. Curr Top Microbiol Immunol. 1990;166:37–41. doi: 10.1007/978-3-642-75889-8_5. [DOI] [PubMed] [Google Scholar]
  5. CASTLEMAN B., IVERSON L., MENENDEZ V. P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956 Jul-Aug;9(4):822–830. doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Cesarman E., Moore P. S., Rao P. H., Inghirami G., Knowles D. M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995 Oct 1;86(7):2708–2714. [PubMed] [Google Scholar]
  7. Corbellino M., Poirel L., Aubin J. T., Paulli M., Magrini U., Bestetti G., Galli M., Parravicini C. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis. 1996 Jun;22(6):1120–1121. doi: 10.1093/clinids/22.6.1120. [DOI] [PubMed] [Google Scholar]
  8. Dupin N., Gorin I., Deleuze J., Agut H., Huraux J. M., Escande J. P. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med. 1995 Sep 21;333(12):798–799. [PubMed] [Google Scholar]
  9. Frizzera G. Castleman's disease: more questions than answers. Hum Pathol. 1985 Mar;16(3):202–205. doi: 10.1016/s0046-8177(85)80002-2. [DOI] [PubMed] [Google Scholar]
  10. Frizzera G., Peterson B. A., Bayrd E. D., Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985 Sep;3(9):1202–1216. doi: 10.1200/JCO.1985.3.9.1202. [DOI] [PubMed] [Google Scholar]
  11. Gaidano G., Pastore C., Gloghini A., Cusini M., Nomdedéu J., Volpe G., Capello D., Vaccher E., Bordes R., Tirelli U. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS. 1996 Aug;10(9):941–949. doi: 10.1097/00002030-199610090-00003. [DOI] [PubMed] [Google Scholar]
  12. Gao S. J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C. R., Saah A., Phair J. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996 Aug;2(8):925–928. doi: 10.1038/nm0896-925. [DOI] [PubMed] [Google Scholar]
  13. Hirano T., Suematsu S., Matsusaka T., Matsuda T., Kishimoto T. The role of interleukin 6 in plasmacytomagenesis. Ciba Found Symp. 1992;167:188–200. doi: 10.1002/9780470514269.ch12. [DOI] [PubMed] [Google Scholar]
  14. Hsu S. M., Waldron J. A., Xie S. S., Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum Pathol. 1993 Aug;24(8):833–839. doi: 10.1016/0046-8177(93)90132-z. [DOI] [PubMed] [Google Scholar]
  15. Kedes D. H., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996 Aug;2(8):918–924. doi: 10.1038/nm0896-918. [DOI] [PubMed] [Google Scholar]
  16. Keller A. R., Hochholzer L., Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972 Mar;29(3):670–683. doi: 10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  17. Klein B., Bataille R. Cytokine network in human multiple myeloma. Hematol Oncol Clin North Am. 1992 Apr;6(2):273–284. [PubMed] [Google Scholar]
  18. Leger-Ravet M. B., Peuchmaur M., Devergne O., Audouin J., Raphael M., Van Damme J., Galanaud P., Diebold J., Emilie D. Interleukin-6 gene expression in Castleman's disease. Blood. 1991 Dec 1;78(11):2923–2930. [PubMed] [Google Scholar]
  19. Lennette E. T., Blackbourn D. J., Levy J. A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996 Sep 28;348(9031):858–861. doi: 10.1016/S0140-6736(96)03240-0. [DOI] [PubMed] [Google Scholar]
  20. Mandler R. N., Kerrigan D. P., Smart J., Kuis W., Villiger P., Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer. 1992 Jun 1;69(11):2697–2703. doi: 10.1002/1097-0142(19920601)69:11<2697::aid-cncr2820691112>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  21. Molden J., Chang Y., You Y., Moore P. S., Goldsmith M. A. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem. 1997 Aug 1;272(31):19625–19631. doi: 10.1074/jbc.272.31.19625. [DOI] [PubMed] [Google Scholar]
  22. Moore P. S., Boshoff C., Weiss R. A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996 Dec 6;274(5293):1739–1744. doi: 10.1126/science.274.5293.1739. [DOI] [PubMed] [Google Scholar]
  23. Nicholas J., Ruvolo V. R., Burns W. H., Sandford G., Wan X., Ciufo D., Hendrickson S. B., Guo H. G., Hayward G. S., Reitz M. S. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med. 1997 Mar;3(3):287–292. doi: 10.1038/nm0397-287. [DOI] [PubMed] [Google Scholar]
  24. Oksenhendler E., Duarte M., Soulier J., Cacoub P., Welker Y., Cadranel J., Cazals-Hatem D., Autran B., Clauvel J. P., Raphael M. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996 Jan;10(1):61–67. [PubMed] [Google Scholar]
  25. Renne R., Lagunoff M., Zhong W., Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol. 1996 Nov;70(11):8151–8154. doi: 10.1128/jvi.70.11.8151-8154.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862–14867. doi: 10.1073/pnas.93.25.14862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Simpson G. R., Schulz T. F., Whitby D., Cook P. M., Boshoff C., Rainbow L., Howard M. R., Gao S. J., Bohenzky R. A., Simmonds P. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996 Oct 26;348(9035):1133–1138. doi: 10.1016/S0140-6736(96)07560-5. [DOI] [PubMed] [Google Scholar]
  28. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995 Aug 15;86(4):1276–1280. [PubMed] [Google Scholar]
  29. Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tagoh H., Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989 Sep;74(4):1360–1367. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES